Endovascular Engineering
Menlo Park
About Endovascular Engineering
Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications. It specializes in developing and implementing clot removal technologies designed for venous thromboembolism, addressing peripheral conditions and equipping healthcare professionals with effective tools to treat pulmonary embolism and deep vein thrombosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $57.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2025)
- Website: endovascularengineering.com
Industries & Categories
Clinical Trials, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/endovascular-engineering-38316 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.